Dr. Wenkert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
thousand oaks
Thousand Oaks, CA 91362
Summary
- I am a pediatric rheumatologist specialized in metabolic bone diseases in academia as well as industry. I am currently a clinical development consultant to industry (Helping with choosing indications, the design and interpretation of development plans, trials and natural history studies, etc.), and see patients about one month per year. I am always interested in learning about opportunities to continue to help research efforts pertaining to rare pediatric diseases and bone diseases. And would also like to hear about opportunities to care for children with metabolic bone diseases.
Education & Training
- Harvard Medical SchoolPost-Doctoral Fellowship, 1991 - 1993
- Tufts Medical CenterFellowship, Rheumatology, 1990 - 1993
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1987 - 1990
- University of Texas Medical Branch School of MedicineClass of 1987
- Rice UniversityB.A., Chemistry, 1975 - 1979
Certifications & Licensure
- CA State Medical License 2022 - 2026
- MO State Medical License 1995 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- Fellow of the American Society for Bone and Mineral Research American Society for Bone and Mineral Research, 2018
- Bravo Awards Amgen, 2011
- Physician Scientist Award National Institutes of Health, 1993
Publications & Presentations
PubMed
- Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin Bmetabolism.Michael P Whyte, Fan Zhang, Karen E Mack, Deborah Wenkert, Gary S Gottesman
Bone. 2024-04-01 - Effects of food, fasting, and exercise on plasma pyrophosphate levels and ENPP1 activity in healthy adults.Gus Khursigara, Pedro Huertas, Deborah Wenkert, Kevin O'Brien, Yves Sabbagh
Bone. 2023-06-01 - 12 citationsWhy are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development., Jennifer Clark, Natalia Muhlemann, Fanni Natanegara, Andrew Hartley
Therapeutic Innovation & Regulatory Science. 2023-05-01
Journal Articles
- Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development.Clark J, Muhlemann N, Natanegara F, Hartley A, Wenkert D, Wang F, Harrell FE Jr, Bray R., Ther Innov Regul Sci., 1/3/2022
- Hypophosphatasia: Natural history study of 101 affected children investigated at one research centerWhyte MP, Wenkert D, Zhang F, Bone, 1/1/2016
- Auricular Ossification: A Newly Recognized Feature of Osteoprotegerin-Deficiency Juvenile Paget DiseaseGottesman GS, Madson KL, McAlister WH, Nenninger AR, Wenkert D, Mumm S, Whyte MP, Am J Med Genetics, 1/1/2016
- Join now to see all
Books/Book Chapters
Press Mentions
- Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical OfficerFebruary 4th, 2021
- Dr. Deborah Wenkert Pediatrics Expert and Former Amgen Clinical Research Medical Director, Joins NDA PartnersFebruary 8th, 2017
Committees
- Chair, Medical Outreach Group (Frequentist Statistics) of the Drug Information Association, Adaptive Design Working Group (DIA-ADSWG) 2018 - Present
- Member, Medical Outreach Group (Bayesian Statistics) of DIA-ADSWG 2018 - Present
- Member, Social Services Ad Hoc Committee, Thousand Oaks 2018 - Present
- Member, ASBMR Advocacy and Science Policy Committee 2017 - Present
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: